- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03707821
Design Validation of Senofilcon A With New UV-blocking Additive
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
Cupertino, California, Estados Unidos, 95014
- James T. Fujimoto, OD
-
-
Florida
-
Maitland, Florida, Estados Unidos, 32751
- Maitland Vision Center
-
Tallahassee, Florida, Estados Unidos, 32308
- Tallahassee Eye Center
-
-
Illinois
-
Bloomington, Illinois, Estados Unidos, 61701
- Eyecare Associates LLP
-
-
Kansas
-
Pittsburg, Kansas, Estados Unidos, 66762
- Kannarr Eye Care
-
-
Ohio
-
Granville, Ohio, Estados Unidos, 43023
- ProCare Vision Centers
-
Westerville, Ohio, Estados Unidos, 43081
- Professional Vision Care, Inc
-
-
Tennessee
-
Memphis, Tennessee, Estados Unidos, 38111
- Bradley Hines, OD
-
-
Texas
-
Tyler, Texas, Estados Unidos, 75703
- Frazier Vision, Inc
-
-
Wisconsin
-
New Berlin, Wisconsin, Estados Unidos, 53151
- Ziegler Leffingwell Eyecare
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
Potential subjects must satisfy all of the following criteria to be enrolled in the study:
- The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
- Appear able and willing to adhere to the instructions set forth in this clinical protocol.
- Between 18 and 49 (inclusive) years of age at the time of informed consent.
- Eligible presbyopes will be those that wear full distance contact lenses in both eyes, then wear reading glasses over them when needed for near vision.
- The subject is a current spherical soft contact lens wearer in both eyes with a minimum of 6 hours/day and 5 days/week wear time over the last 30 days by self-report.
- Subjects must be able and willing to wear the study lenses at least 6 hours a day, a minimum of 5 days per week.
- Subjects must own a wearable pair of distance spectacles.
- The subject's vertex-corrected spherical equivalent distance refraction must be in the range of -1.00 to -6.00 D (inclusive) in each eye.
- The subject's refractive cylinder must be 0.00 to -1.00 D (inclusive) in each eye.
The subject must have a spherocylindrical best corrected distance Snellen visual acuity of 20/25+3 or better in each eye.
Exclusion Criteria:
Potential subjects who meet any of the following criteria will be excluded from participating in the study:
- Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
- Any active or ongoing systemic disease (e.g., Sjögren's Syndrome), infectious disease (e.g., hepatitis, tuberculosis), contagious immunosuppressive diseases (e.g., HIV), autoimmune disease (e.g. rheumatoid arthritis).
- Subjects taking suspect oral medications for less than one year.
- Any prescribed or over the counter (OTC) ocular medication.
- Any known hypersensitivity or allergic reaction to Optifree® PureMoist® multi-purpose care solution or Eye-Cept® rewetting drop solution.
- Toric, extended wear, monovision or multi-focal contact lens correction.
- Any previous or planned (during the course of the study) ocular surgery (e.g., PRK, LASIK, etc.).
- Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.
- Participation in clinical trials involving the Test lens within 3 months prior to study enrollment.
- Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).
- Binocular vision abnormality or strabismus by self-report or prior medical history.
- History of recurrent corneal erosions, herpetic keratitis, or pathological dry eye.
- Any active ocular allergies, infections or other ocular abnormalities (entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma) that the investigator determines may interfere with the outcomes of this study or otherwise contraindicate participation in the study.
- Any Grade 2 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA Slit Lamp Classification Scale.
- Any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar) within the past 3 years of otherwise successful contact lens wear.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: senofilcon A TEST Lens
Subjects between 18 to 49 years of age that are habitual wearers of spherical soft contact lenses will be randomized into the TEST Lens for the duration of the clinical study.
|
JJVC Investigational Contact Lens
|
Comparador Ativo: senofilcon A CONTROL Lens
Subjects between 18 to 49 years of age that are habitual wearers of spherical soft contact lenses will be randomized into the CONTROL Lens for the duration of the clinical study.
|
Acuvue Oasys
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Overall Comfort Score
Prazo: 2-Week Follow-up Evlauation
|
Overall comfort was assessed using the Contact Lens User Experience™ (CLUE) questionnaire.
CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patientexperience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65.
Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
|
2-Week Follow-up Evlauation
|
Vision Satisfaction in Bright Lighting
Prazo: 2-Week Follow-up Evaluation
|
Vision satisfaction in bright light was assessed using the individual item" I was satisfied with the quality of my vision in bright lighting" from the CLUE™ questionnaire.
This item used the response scale, 1: Strongly Disagree, 2: Disagree, 3: Neither Agree nor Disagree, 4: Agree and 5: Strongly Agree.
CLUE is the Contact Lens User Experience™ questionnaire.
CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65.
Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
The Proportion of responses in each category were reported for each lens type.
|
2-Week Follow-up Evaluation
|
Distance Visual Acuity
Prazo: 2-Week Follow-up Evlauation
|
Distance visual acuity was assessed by eye using LogMAR visual acuity at 4 meters using an ETDRS chart under high illumination high contrast conditions (room illumination > 400 lux and chart luminance 120-200 cd/m2) at the 2-week follow-up for each subject eye.
Lower values of logMAR indicate better vision, where a score of 0.0 equates to 20/20 snellen vision.
The average visual acuity for each lens was reported.
|
2-Week Follow-up Evlauation
|
Contact Lens Fitting Acceptance Rate
Prazo: Up to 2-Week Follow-up
|
Acceptable lens fit will be assessed at all study visits (scheduled and unscheduled) for each subject eye. Fit acceptance rate will be based on the lens fit acceptance of eyes wearing the Test lens only. Fit acceptance is a binary response where Y=1 if lens fit is acceptable and Y=0 otherwise. Unacceptable is defined as unacceptable if any one of the following criteria:
Eyes with multiple unacceptable fitting events will be counted only once. Fit rates of the Control lens will also be collected but are not a primary endpoint. |
Up to 2-Week Follow-up
|
Number of Grade 3 or Higher Slit Lamp Findings
Prazo: Up to 2-Week Follow-up Evlauation
|
Slit Lamp Findings (SLF) were assessed using a biomicroscope and was graded using the FDA grading scale (Grade: 0, 1,2, 3 and 4) with grade 0 represents the absence of findings and 1 to 4 representing successively worse findings (i.e.
Grade 1 = trace, Grade 2 = Mild, Grade 3 = moderate and Grade 4 = severe).
Slit Lamp Findings will be assessed for each subject eye at all study visits (schedule and unscheduled).
SLF is a binary response where Y=1 for at least one Grade 3 or 4 slit lamp finding.
The percentage of eyes with Grade 3 or higher slit lamp findings will be analyzed and will include corneal infiltrates.
Eyes with multiple events will be counted only once.
The number of eyes with SLF with grade 3 or higher by lens was reported.
|
Up to 2-Week Follow-up Evlauation
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Overall Handling Score
Prazo: 2-Week Follow-up Evlauation
|
Overall handling was assessed using the Contact Lens User Experience™ (CLUE) questionnaire.
CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patientexperience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65.
Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
|
2-Week Follow-up Evlauation
|
Overall Quality of Vision Score
Prazo: 2-Week Follow-up Evlauation
|
Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire.
CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patientexperience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65.
Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.
|
2-Week Follow-up Evlauation
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- CR-6305
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Acuidade visual
-
Brigham and Women's HospitalRecrutamentoDescobertas incidentais | Atenção visual | Pesquisa Visual | Pesquisa HíbridaEstados Unidos
-
Stanford UniversityNational Eye Institute (NEI)Inscrevendo-se por conviteEstimulação Magnética Transcraniana Repetitiva | Atenção visual | Plasticidade Cortical VisualEstados Unidos
-
Weill Medical College of Cornell UniversityConcluídoPressão intraocular | Acuidade visual | Distúrbio visualEstados Unidos
-
University of TorontoKensington Eye InstituteRescindidoCatarata | Acuidade visual reduzida transitoriamente | Perda de Sensibilidade de Contraste Visual | Perda Visual FuncionalCanadá
-
Johnson & Johnson Vision Care, Inc.Ainda não está recrutandoAcuidade visualEstados Unidos
-
Johnson & Johnson Vision Care, Inc.RecrutamentoAcuidade visualEstados Unidos
-
Johnson & Johnson Vision Care, Inc.ConcluídoAcuidade visualHong Kong
-
Johnson & Johnson Vision Care, Inc.ConcluídoAcuidade visualReino Unido
-
Johnson & Johnson Vision Care, Inc.Concluído
-
Johnson & Johnson Vision Care, Inc.Concluído
Ensaios clínicos em senofilcon A TEST Lens
-
Lemonex Inc.ConcluídoCicatriz | Prevenção de cicatrizesRepublica da Coréia
-
Johnson & Johnson Vision Care, Inc.Concluído
-
Johnson & Johnson Vision Care, Inc.ConcluídoDesgaste de lentes de contato por lapsoEstados Unidos
-
Istinye UniversityInscrevendo-se por conviteDerrame | Teleavaliação | O teste Timed Up & Go | Teste de levantar da cadeira de 30 segundosPeru
-
Assistance Publique - Hôpitaux de ParisDesconhecidoVentilação mecânicaFrança
-
Johnson & Johnson Vision Care, Inc.Concluído
-
Johnson & Johnson Vision Care, Inc.ConcluídoAcuidade visualEstados Unidos
-
Johnson & Johnson Vision Care, Inc.Concluído
-
Johnson & Johnson Vision Care, Inc.ConcluídoCorreção de erro de refração | Atenuação da luz brilhanteEstados Unidos